Anika Therapeutics, Inc.: capex
| Value | {"amount": 1431000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/95a52638-d985-44d9-9fa6-276968152514
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-26-002852Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/capex/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/95a52638-d985-44d9-9fa6-276968152514
History
- no predecessors — first report